Medacta Group SA Provides Revenue Guidance for the Year 2022
July 29, 2022 at 01:00 am EDT
Share
Medacta Group SA provided revenue guidance for the year 2022. For the full-year revenue is expected in the top end of the original guidance range of EUR 400 million to EUR 414 million, at constant currency.
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
MEDACTA GROUP SA 
